PHARMA MAR, S.A. «...678910...» Page 6 out of 18 from 01/07/1988 to 29/04/2024 The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 16/10/2018 15:29 PHARMA MAR, S.A. Others on business performance and financial information Pharma Mar´s statement is attached. Register number: 270531 04/10/2018 11:23 PHARMA MAR, S.A. Liquidity contracts and specialists The Company reports details of the operations of the Liquidity Agreement between 05/06/2018 and 28/09/2018 Register number: 270156 Related with 266399 of 04/06/2018 (17:39) 02/10/2018 08:14 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Pharma Mar´s application before the General Court of the European Union requesting the annulment of the refusal of the marketing authorisation for Aplidin. Register number: 270099 Related with 263165 of 21/03/2018 (19:24) 20/09/2018 14:14 PHARMA MAR, S.A. Transmissions and purchases of capital undertakings The Company announces the sale of its subsidiary Xylazel, S.A. Register number: 269749 07/09/2018 08:18 PHARMA MAR, S.A. Other on financial instruments Pharma Mar announces its intention to conduct a registered public offering of American Depositary Shares representing its shares in US Register number: 269450 03/08/2018 08:23 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Lurbinectedin has been granted orphan drug status by the FDA for the treatment of small cell lung cancer. Register number: 268855 30/07/2018 16:10 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Pharma Mar announces that 600 patients have been already recruited in the Phase III clinical trial ATLANTIS in in relapsed small-cell lung cancer with lurbinectedin. Register number: 268655 27/07/2018 11:47 PHARMA MAR, S.A. Others on business performance and financial information Execution of an agreement between Pharma Mar and Impilo Pharma for the exclusive promotion and distribution of Yondelis throughout the Nordic countries and Eastern Europe Register number: 268553 26/07/2018 17:54 PHARMA MAR, S.A. Information on P&L The Company sends press release regarding first half 2018 results. Register number: 268438 26/07/2018 17:49 PHARMA MAR, S.A. Interim financial information La sociedad remite información sobre los resultados del primer semestre de 2018 Register number: 268434 Page 6 out of 18 «...678910...»